2020 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | > 1000 |
2012 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Networking Rank (Reputation): | > 1000 |
2008 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 5
As coordinator: 0
As participant: 5
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2022 | 0 | 2.410.866 | 53.423 | 1 | ||
2021 | 0 | 14.998.354 | 127.373 | 1 | ||
2020 | 0 | 9.993.475 | 80.831 | 1 | ||
2012 | 0 | 5.978.735 | 217.242 | 1 | ||
2010 | 0 | 11.187.685 | 13.172 | 1 |
Total number of partners: 118
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 118
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2022-10-01 | 2PS - Prevent & Protect Through Support | 2PS | participant | 2.410.866 | 22 |
2021-03-01 | Revolution of sleep diagnostics and personalized health care based on digital diagnostics and therapeutics with health data integration | SLEEP REVOLUTION | participant | 14.998.354 | 39 |
2020-11-01 | Pan-European Response to the ImpactS of COVID-19 and future Pandemics and Epidemics | PERISCOPE | participant | 9.993.475 | 32 |
2012-01-01 | Development of a novel FGL therapy and translational tests for regenerative treatment of neurological disorders | NEUROFGL | participant | 5.978.735 | 7 |
2010-02-01 | OPtimization of Treatment and Management of Schizophrenia in Europe (OPTiMiSE) | OPTiMiSE | participant | 11.187.685 | 23 |